A precise and portable in-vitro device that brings efficiency to the hematological diseases diagnostics with a single blood drop.
RheoDx has raised €350k across 1 funding round from 2 investors, most recently a round in Apr 2019. Based in Barcelona, Spain; founded 2018; active in Healthtech. Data as of 6 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-04-01 | Other | €350k |
| Capital Cell,mVenturesBCN |
| View deal → |
